info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Superdisintegrants Market Analysis

ID: MRFR//5200-HCR | 100 Pages | Author: Rahul Gotadki| November 2024

Superdisintegrants in the pharmaceutical market dynamics show how crucial these compounds are to pharmaceutical formulations by their role of improving the rate of dissolution and bioavailability. In tablet and capsule formulations, superdisintegrants are primary excipients to facilitate quick breakdown of the dosage form into small particles for fast drug release. The pharmaceutical superdisintegrants market is influenced by many factors including, rising pharmaceutical industry, increasing demand for innovative drug delivery systems and emphasis on patient compliance.

Pharmaceutical market expanding is major reason for growth of the market for Pharmaceutical Superdisintegrant. As new and improved formulations are being sought by drug manufacturers, they need effective superdisintegrants. These substances enhance disintegration of tablet or capsule thereby speeding up dissolving as well as absorption of active pharmaceutical ingredient (API). Superdisintegrant market offers various types such as crospovidone, croscarmellose sodium, sodium starch glycolate that are broadly used.

Another important aspect impacting the dynamics in this segment is focus on innovative drug delivery systems and patient-friendly formulation. In light of patient compliance era, it becomes a priority issue to create fast-dissolving tablets, orally-dispersible tablets and other novel dosage forms. For these innovations to happen there has to be an enabling environment which includes superdisintegrants aiding in easy administration and improving patients’ adherence. This eventually adjusts market supply by offering a wide range of superdisintegrants that meet different requirements of drug delivery technologies involved.

Market dynamics also take into account the regulatory considerations about the use of Pharmaceutical Super Disintegrated Excipients by different regulatory bodies to ensure safety, efficacy and quality control measures for drugs formulated with excipients. This therefore calls for strict compliance on the part of all such regulated players otherwise they risk losing out in terms access to suppliers who stock high quality materials from such conformance companies like perrier . This regulatory context allows better quality products from top rating manufacturers of super-disintegrated excipients enhancing trust among industry players.

The pharmaceutical superdisintegrant market is influenced by advances in research and technology. Continual research is focused on better performance, stability as well as compatibility of Super Disintegrants with various drug formulations. Technological innovation embraced by the market ensures that these Superdisintegrants are endowed with superior features such as improved disintegration efficiency; can be applied with different APIs and formulation as a whole. As a result, they have emerged to be versatile in different pharmaceuticals.

Additionally, global healthcare trends also shape the dynamics within the pharmaceutical super disintegrated excipients market. On a worldwide scale various health care systems emphasize on patient centric approaches forcing manufacturers to look for formulations that improve overall patient experience. In pursuit of this goal, superdisintegrants enable rapid disintegration of dosage forms making drugs more accessible and convenient to patients. The market adapts to this need through provision of appropriate products that align with patient-centered health care agendas.

Economic considerations are also important when looking at the pharmaceutical super disintegrated excipient market, especially because drug makers want cost effective additives without compromising quality. This can be addressed by providing low-cost options where cost runs parallel to efficacy levels among other performances aspects for a number of different types having distinct prices under this category- for example, tablets made from wheat starch will come cheaper than those made from corn starch if you were buying them in bulk. Therefore, companies involved in sales may choose between staying within their budgets or making some savings while opting for particular superdisintegrants fitting their needs perfectly yet being affordable ones.

Global Superdisintegrants Market Overview 


Superdisintegrants Market Size was valued at USD 3.73 Billion in 2023. The Global Superdisintegrants industry is projected to grow from USD 4.07 Billion in 2024 to USD 7.37 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 8.43% during the forecast period (2024 - 2032).


Superdisintegrants Market


Latest Industry Developments in Superdisintegrants Market

March 2024,Asahi Kasei has introduced a new superdisintegrant with enhanced swelling properties and improved disintegration efficiency, aiming to optimize tablet formulation and dissolution rates for better drug delivery by improving uniformity of disintegration.


May 2024,DFE Pharma has introduced a new cellulose-based superdisintegrant that enhances tablet mechanical strength and rapid disintegration, addressing challenges in high-dose formulations.


Disintegrants are chemicals added to medicine formulas to aid in the disintegration of capsules and tablets into easily dissolved particles. This is important for the rapid absorption of the medicine, which improves its potency. Superdisintegrants are disintegrants with small modifications that are more efficient than their standard equivalents. The pharmaceutical industry is rapidly expanding and has become an important aspect of the healthcare industry. This is mostly attributable to an increase in the number of geriatric and pediatric patients. 



Patients in this population benefit from super disintegrants because the tablets are simpler to swallow. These demographics are projected to drive market expansion. Furthermore, generic medications are in high demand since patents on some major prescription names have begun to expire, opening the pharmaceutical sector to increased competition and a rise in generic drug manufacturing, fuelling demand for superdisintegrants. Emerging markets provide enormous opportunities because their healthcare sectors are rapidly expanding. Furthermore, huge patient populations in these countries are projected to drive up the demand for fast-acting drugs. Market companies are likely to establish themselves in the region to take advantage of emerging market prospects.


Superdisintegrants Market Trends



MRFR's global superdisintegrants market report contains an entire historical analysis along with current trends to assemble a panoramic view of the market. Drivers, restraints, threats, and opportunities have been expounded in the report along with projections for the future of the market over the forecast period from 2024 to 2032. All parameters relevant to the global superdisintegrants market have been taken into account including the various parts of the market which have been segmented on the basis of types, formulation, therapeutic area, and region. Moreover, various key players operating in the market's competitive landscape have been profiled to provide an impact analysis of various vital growth strategies.


Key Companies in the superdisintegrants market include



  • Asahi Kasei Corporation

  • DFE Pharma

  • JRS Pharma

  • Corel Pharma Chem

  • Ashland Global Holdings Inc.

  • BASF SE

  • Roquette Freres

  • DowDuPont Inc.

  • Merck KGaA

  • Avantor Performance Materials, LLC


Research Methodology


Market Research Future's market report on the surface disinfectant market has employed various proprietary research methods to ascertain the forecast of the market. Primary data sources such as personal one-on-one interviews with marketing directors, and other important executives, thus providing a deeper insight into industry performance and expectations of the market. Meanwhile, secondary sources of data which refer to both internal and external sources such as customer feedback, analysis of marketing activities, industry publications, annual reports, and others are useful for a full commercial study of the global surface disinfectant market. Moreover, MRFR's data analysts use both top-down and bottom-up approaches for the estimation and validation of Superdisintegrants Market size. All data is processed, analyzed and consolidated into brief palatable reports which include intelligent observations regarding various important Superdisintegrants Market factors. 


Recent Development


Roquette built a new Pharmaceutical R&D and Customer Technical Service (CTS) in Biopolis (Singapore) in October 2017 for the development of new medicines, new applications for current products, and preclinical research. Roquette's Asia Pacific headquarters is located here, and it concentrates on food, nutrition, and pharmaceutical products. DFE Pharma's supply chain of pharmaceutical excipients was effectively streamlined in July 2018. Furthermore, the company has made significant investments in factory capacity development to address the global demand for high-quality excipients such as pharmaceutical grade Lactose and Microcrystalline Cellulose (MCC). Ashland launched a new pharmaceutical excipient factory in Nanjing, China, in October 2016, to create excipients for the Asian market. This laboratory provides highly functioning excipient technology to oral pharmaceutical makers as well as tailor-made formulation solutions.

Superdisintegrants Market Segmentation


Superdisintegrants Type Outlook



  • Synthetic Superdisintegrants

  • Natural Superdisintegrants

  • Other Superdisintegrants


Superdisintegrants Formulation Outlook



  • Tablets

  • Capsules


Superdisintegrants Therapeutic Area Outlook



  • Neurological Diseases

  • Gastrointestinal Diseases

  • Oncology

  • Inflammatory Diseases

  • Cardiovascular Diseases

  • Hematological Diseases

  • Infectious Diseases


Superdisintegrants Regional Outlook



  • Americas

  • Europe

  • Asia-Pacific

  • Middle East & Africa


Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.